GSK Validates Chai Discovery's AI Models for Drug Discovery
GSK has validated and incorporated Chai Discovery's AI models into its drug discovery workflow following successful wet lab testing. The partnership represents a concrete example of AI models transitioning from computational benchmarks to real-world pharmaceutical applications. Chai Discovery's technology, which focuses on protein structure and molecular interaction modeling, was verified against physical laboratory results before GSK committed to using the system. This validation approach—combining AI predictions with empirical laboratory data—has become a standard for pharma companies evaluating AI tools, as it helps ensure computational findings translate to actual biological systems.